Paroxetine
پاروکستین
🧠 Nervous SystemSSRI
Market / country: 🇺🇸 USA
Paxil (US) · Seroxat (GB)
🧮 Dose calculator
Major depressive disorder · Regimen source: FDA Paroxetine · 2.2, Table 1
- • Elderly or severe renal/hepatic impairment: start 10 mg, max 40 mg. FDA Paroxetine · 2.5
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ With or within 14 days of an MAOI (including linezolid or IV methylene blue). FDA Paroxetine · 4
- ⛔ Not approved for pediatric use. FDA Paroxetine · 8.4
- ⚠️ Boxed warning: increased suicidal thoughts and behaviour in children, adolescents and young adults. FDA Paroxetine · Boxed Warning
Formulations
- 10 mg tablet — tablet 🇺🇸 USA FDA Paroxetine · 3
- 20 mg tablet — tablet 🇺🇸 USA FDA Paroxetine · 3
- 30 mg tablet — tablet 🇺🇸 USA FDA Paroxetine · 3
- 40 mg tablet — tablet 🇺🇸 USA FDA Paroxetine · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Paroxetine · 8.1
“Risk Summary Based on data from published observational studies, exposure to SSRIs, particularly in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage [see Warnings and Precautions ( 5.5 ) and Clinical Considerations].”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Paroxetine · 8.2
“Risk Summary Data from the published literature report the presence of paroxetine in human milk (see Data).”
- 👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Paroxetine · Boxed Warning
“WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Paroxetine · 8.5
“SSRIs including paroxetine, have been associated with cases of clinically significant hyponatremia in elderly patients, who may be at greater risk for this adverse reaction [see Warnings and Precautions ( 5.7 )].”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Paroxetine · 8.3
“Infertility Male Based on findings from clinical studies, paroxetine may affect sperm quality which may impair fertility; it is not known if this effect is reversible [see Nonclinical Toxicology ( 13.1 )].”
🔗 Reference links
- FDA (approval record)ANDA077584
- DailyMed (FDA label)FDA Paroxetine
- MedlinePlus (NIH)Paroxetine
- WHO ATC/DDDN06AB05
- Darooyab (Iran)Paroxetine
🇮🇷 Registered in Iran Darooyab · G-604/Paroxetine
Dosage forms with Iranian generic codes, per Darooyab.
- 20409 · PAROXETIN 10MG TAB · قرص پاروکستین ۱۰ میلیگرم
- 05932 · PAROXETIN 20MG TAB · قرص پاروکستین ۲۰ میلیگرم
- 09975 · PAROXETIN 30MG TAB · قرص پاروکستین ۳۰ میلیگرم
- 23027 · PAROXETIN 40MG TAB · قرص پاروکستین ۴۰ میلیگرم
- 52184 · PAROXETINE (AS MESILATE) TABLET ORAL 20 mg · قرص پاروکستین (معادل مزیلات) ۲۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Paroxetine · 3FDA Paroxetine · 2.2, Table 1FDA Paroxetine · 2.5FDA Paroxetine · 2.3FDA Paroxetine · 4FDA Paroxetine · 8.4FDA Paroxetine · Boxed WarningFDA Paroxetine · 8.1FDA Paroxetine · 8.2FDA Paroxetine · 8.5FDA Paroxetine · 8.3FDA Paroxetine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-604/Paroxetine
- Clinical review⚠ Unverified